Xvivo Perfusion

274.40 SEK

-0.72%

Less than 1K followers

XVIVO

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Xvivo Perfusion

P/E

Median 2019-2025

EV/S

Median 2019-2024

EV/EBIT

Median 2019-2024

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (SEK)170.00314.00278.50183.00329.50489.00186.60
Shares26.527.028.729.831.531.531.5
Market cap4,502.38,482.17,998.25,459.210,379.115,403.25,877.8
Enterprise value4,347.98,197.67,605.35,222.79,864.415,021.8-
EV/S19.745.629.412.616.518.3-
EV/EBITDA151.0neg.552.7107.5122.585.3-
EV/EBIT1,103.5neg.neg.814.82,354.3170.0-
P/E912.0neg.981.3295.2107.389.4233.2
P/B7.808.416.223.825.347.142.78
P/S20.447.231.013.117.418.77.2
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio91.0 %87.7 %83.3 %82.5 %89.2 %89.8 %89.0 %
Gearing ratio1.0 %6.9 %0.4 %0.7 %1.6 %1.6 %5.9 %